Emergent autoimmunity in graft-versus-host disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Blood

• Publication date

  2005-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2004-12-4980PMID 15746077PMCID PMC1894995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graft-versus-host disease

  2007cited by this paper
• Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II

  2004cited by this paper
• Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

  2004cited by this paper
• Association of Foxp3 regulatory gene expression with graft-versus-host disease.

  2004cited by this paper
• Massive Thymic Deletion Results in Systemic Autoimmunity through Elimination of CD4+ CD25+ T Regulatory Cells

  2004cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Donor APCs are required for maximal GVHD but not for GVL

  2004cited by this paper
• Pathophysiology of acute graft‐versus‐host disease

  2003cited by this paper
• Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1

  2003influential reference
• Impaired thymic negative selection causes autoimmune graft-versus-host disease.

  2003cited by this paper
• APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease1

  2002cited by this paper
• Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients.

  2002influential reference
• The immunology of mucosal models of inflammation.

  2002cited by this paper
• Role of the Passive Apoptotic Pathway in Graft-Versus-Host Disease1

  2002cited by this paper
• Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.

  2000cited by this paper
• Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation.

  2000cited by this paper
• Dysregulated myelopoiesis in mice lacking Jak3.

  1999cited by this paper
• Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles.

  1999cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease.

  1999cited by this paper
• Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.

  1998cited by this paper
• Autoimmune diseases and autoimmunity post-bone marrow transplantation

  1998cited by this paper
• Processing of engulfed apoptotic bodies yields T cell epitopes.

  1997cited by this paper
• Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

  1995cited by this paper
• Graft-versus-host disease

  1994cited by this paper
• Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.

  1994cited by this paper
• Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.

  1994cited by this paper
• Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity

  1994cited by this paper
• Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.

  1994cited by this paper
• Is chronic graft versus host disease an autoimmune disease?

  1993cited by this paper
• Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

  1993cited by this paper
• Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice.

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

  1993cited by this paper
• Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions

  1993cited by this paper
• Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection

  1992cited by this paper
• T cell recognition of allopeptides in context of syngeneic MHC.

  1991cited by this paper
• Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.

  1990cited by this paper
• AUTOIMMUNITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION A STUDY OF 53 LONG‐TERM‐SURVIVING PATIENTS

  1988cited by this paper
• Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma

  1987cited by this paper
• Ability of fixed B-lymphoma cells to present foreign protein antigen fragments and allogenic MHC molecules to a cloned helper-T-cell line.

  1987cited by this paper
• Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

  1986cited by this paper
• Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease.

  1986cited by this paper
• Allogeneic Bone‐Marrow Transplantation

  1983cited by this paper
• Graft-versus-Host reactions: a review.

  1976cited by this paper

• Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.

  2026cites this paper
• Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.

  2025cites this paper
• Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China.

  2024cites this paper
• CNS manifestations in acute and chronic graft-versus-host disease

  2024cites this paper
• Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions

  2023cites this paper
• Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD

  2023cites this paper
• Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation.

  2023cites this paper
• Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

  2022cites this paper
• Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.

  2022cites this paper
• Engineered cellular immunotherapies in cancer and beyond

  2022cites this paper
• Biology of Graft-Versus-Host Disease

  2021cites this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

  2021cites this paper
• Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity

  2020cites this paper
• Thalidomide as treatment of crohn‐like disease occurred after allogeneic hematopoietic stem cell transplantation in a pediatric patient

  2020cites this paper
• Biomarkers for acute and chronic graft versus host disease: state of the art

  2020cites this paper
• Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity.

  2020cites this paper
• One-two punch injury to tolerance mechanisms in graft-versus-host disease.

  2020cites this paper
• Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease

  2019cites this paper
• Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience

  2019cites this paper
• Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children.

  2019cites this paper
• An investigation into the phenotype, function and immunomodulatory properties of in vitro expanded iNKT cells

  2019cites this paper
• The Apex Set-Up for the Major Transitions in Individuality

  2019cites this paper
• Summary and Outlook on the Future Challenges of Allogeneic HSCT

  2019cites this paper
• B cells in chronic graft-versus-host disease.

  2019cites this paper
• PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease

  2018cites this paper
• B-cell targeting in chronic graft-versus-host disease.

  2018cites this paper
• Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

  2017cites this paper
• An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

  2017cites this paper
• The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

  2017influential citation
• Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency?

  2017cites this paper
• Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

  2017cites this paper
• Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

  2017cites this paper
• Series CHRONIC GRAFT-VERSUS-HOST DISEASE Chronic graft-versus-host disease : biological insights from preclinical and clinical studies

  2016cites this paper
• Antibodies are back for thymic attack in cGVHD.

  2016cites this paper
• Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.

  2016cites this paper
• Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation

  2016cites this paper
• B cells in chronic graft-versus-host disease.

  2015cites this paper
• Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients.

  2015cites this paper
• Reprint of: B cells in chronic graft-versus-host disease.

  2015cites this paper
• Graft-Versus-Host-Disease nach NIH-Klassifikation bei Patienten mit Akuter Lymphatischer Leukämie: Klinische Präsentation, Prognostische Relevanz und Nachweis eines Potenten Graft-Versus-Leukämie-Effekts

  2015cites this paper
• Aberrant B-cell homeostasis in chronic GVHD.

  2015influential citation
• Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis

  2014influential citation
• Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

  2014cites this paper
• Title Oral complications and management strategies for patientsundergoing cancer therapy

  2014cites this paper
• Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

  2014cites this paper
• Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience.

  2014cites this paper
• Pulmonary Manifestations of Hematological Malignancies: Focus on Pulmonary Chronic Graft-Versus Host Disease

  2014cites this paper
• Oral Complications and Management Strategies for Patients Undergoing Cancer Therapy

  2014cites this paper
• The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success

  2013cites this paper
• CD11c+CD86+ cells with direct and indirect antigen-presenting function Allogeneic T cells induce rapid CD34+ cell differentiation into

  2013cites this paper
• biomarkers of chronic graft-versus-host disease MICA-129 genotype, soluble MICA, and anti-MICA antibodies as

  2013cites this paper
• Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease

  2013cites this paper
• This information is current as T Cells + and CD 8 + CD 4 Graft-versus-Host Disease Caused by Donor Selection , and Development of Chronic Thymic Damage , Impaired Negative

  2013cites this paper
• Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells

  2013cites this paper
• CD123 is a useful immunohistochemical marker to facilitate diagnosis of acute graft-versus-host disease in colon.

  2013cites this paper
• Role of TH17 Cells and Interleukin 17 in Graft Versus Host Disease and Graft Versus Leukemia Reactivity

  2013cites this paper
• Donor B Cells in Transplants Augment Clonal Expansion and Survival of Pathogenic CD4+ T Cells That Mediate Autoimmune-like Chronic Graft-versus-Host Disease

  2012cites this paper
• Complications of transplant for nonmalignant disorders: autoimmune cytopenias, opportunistic infections, and PTLD.

  2012cites this paper
• Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.

  2012cites this paper
• Clinical Applications for Biomarkers of Acute and Chronic Graft vs. Host Disease

  2012cites this paper
• Donor T cell outcome and immune reconstitution following post-transplant cyclophosphamide and regulatory MHC cell therapy in recipients of mhc matched allogeneic hematopoietic stem cell transplants

  2012cites this paper
• Alloantigen‐specific regulatory T cells prevent experimental chronic graft‐versus‐host disease by simultaneous control of allo‐ and autoreactivity

  2012cites this paper
• DiseaseAutoimmune-like Chronic Graft-versus-Host T Cells That Mediate + CD4 Pathogenic Clonal Expansion and Survival of Donor B Cells in Transplants Augment

  2012cites this paper
• Clinical applications for biomarkers of acute and chronic graft-versus-host disease.

  2012cites this paper
• Mouse models of graft-versus-host disease: advances and limitations

  2011cites this paper
• Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

  2011cites this paper
• Quo vadis chimerism?

  2011cites this paper
• Chronic Graft Versus Host Disease: Inflammation at the Crossroads of Allo and Auto Immunity

  2011cites this paper
• Alloimmune Response Results in Expansion of Autoreactive Donor CD4+ T Cells in Transplants That Can Mediate Chronic Graft-versus-Host Disease

  2011cites this paper
• Graft-versus-host disease therapy: something else beyond glucocorticoids?

  2011cites this paper
• graft-versus-host disease with autoimmune manifestations T and B cells in transplants induce chronic + Donor CD4

  2011cites this paper
• Acute graft‐versus‐host disease following hematopoietic stem‐cell transplantation

  2011cites this paper
• The Spectrum of Lung Involvement in Collagen Vascular-Like Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation: Report of 6 Cases and Review of the Literature

  2011cites this paper
• Ü-BOEFT#JPTDJFODF %POPUEJTUSJCVUF

  2011cites this paper
• Graft-Versus-Host Disease in a Murine Model the Pathogenesis of Chronic Sclerodermatous T Cells Is Critical for + STAT3 Signaling in CD4

  2011cites this paper
• Health consensus criteria and for chronic graft-versus-host disease according to National Comparative analysis of risk factors for acute graft-versus-host disease

  2011cites this paper
• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

  2011cites this paper
• Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.

  2011cites this paper
• Reconstitution of self-tolerance after hematopoietic stem cell transplantation

  2010influential citation
• Bone marrow transplantation across major genetic barriers

  2010cites this paper
• Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease.

  2010cites this paper
• The role of the thymus in hematopoietic stem cell transplantation

  2010cites this paper
• Early‐onset lichenoid graft‐vs.‐host disease: a unique variant of acute graft‐vs.‐host disease occurring in peripheral blood stem cell transplant recipients

  2010cites this paper
• Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.

  2010cites this paper
• Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.

  2010cites this paper
• Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease

  2010cites this paper
• MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease.

  2009cites this paper
• STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model

  2009cites this paper
• Regulatory mechanisms in graft-versus-host responses.

  2009cites this paper
• Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.

  2009cites this paper
• Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.

  2009cites this paper
• Chronic Graft-versus-Host Disease - Clinical Manifestations and Therapy

  2009cites this paper
• Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

  2009influential citation
• Biology and management of chronic graft-versus-host disease.

  2009cites this paper
• Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

  2009cites this paper
• Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

  2009cites this paper
• Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.

  2008cites this paper
• Chronic graft-versus-host disease: how can we release Prometheus?

  2008influential citation
• Chronic graft-versus-host disease.

  2008cites this paper
• Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.

  2008cites this paper